Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammation

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Holt, David ^a   Okusanya, Olugbenga ^b   Judy, Ryan ^b   Venegas, Ollin ^b   Jiang, Jack ^b   DeJesus, Elizabeth ^b   Eruslanov, Evgeniy ^b   Quatromoni, Jon ^b   Bhojnagarwala, Pratik ^b   Deshpande, Charuhas ^b   Albelda, Steven ^b   Nie, Shuming ^c   Singhal, Sunil ^b  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATELECTASIS; CANCER SURGERY; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; DOG; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAOPERATIVE PERIOD; LUNG CANCER; LUNG LOBECTOMY; MALE; MOUSE; NEAR INFRARED IMAGING; NONHUMAN; PILOT STUDY; SARCOMA; SOLID TUMOR; THORAX WALL TUMOR; THYMOMA; ANIMAL; CANCER STAGING; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; DISEASE MODEL; LUNG NEOPLASMS; MIDDLE AGED; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; TUMOR VOLUME;

AGED; ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HUMANS; INDOCYANINE GREEN; INFLAMMATION; INTRAOPERATIVE PERIOD; LUNG NEOPLASMS; MICE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED; TUMOR BURDEN;

EID: 84905016688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103342     Document Type: Article

References (35)

1. Aliperti LA, Predina JD, Vachani A, Singhal S (2011) Local and systemic recurrence is the Achilles heel of cancer surgery. Ann Surg Oncol 18: 603-607.
2. NCI (2009) Surveillance, Epidemiology, and End Results (SEER) Program. Nov 2009 Sub (1973-2007) 〈Katrian/Rita Population Adjustment〉 ed. Bethesda: SEER Stat Database.
3. Klimberg VS, Harms S, Korourian S (1999) Assessing margin status. Surg Oncol 8: 77-84. (Pubitemid 30224700)
4. Vaidya A, Hawke C, Tiguert R, Civantos F, Soloway M (2001) Intraoperative T staging in radical retropubic prostatectomy: is it reliable? Urology 57: 949-954. (Pubitemid 32405319)
5. Singhal S, Nie S, Wang MD (2010) Nanotechnology applications in surgical oncology. Annu Rev Med 61: 359-373.
6. Madajewski B, Judy BF, Mouchli A, Kapoor V, Holt D, et al. (2012) Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res 18: 5741-5751.
7. Frangioni JV (2006) Translating in vivo diagnostics into clinical reality. Nat Biotechnol 24: 909-913.
8. Sevick-Muraca EM (2012) Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 63: 217-231.
9. Nguyen QT, Tsien RY (2013) Fluorescence-guided surgery with live molecular navigation - a new cutting edge. Nat Rev Cancer 13: 653-662.
10. Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, et al. (2007) Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 67: 6882-6888. (Pubitemid 47105535)
11. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, et al. (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol.
12. Schulz MD, Khullar O, Frangioni JV, Grinstaff MW, Colson YL (2010) Nanotechnology in thoracic surgery. Ann Thorac Surg 89: S2188-2190.
13. Choi HS, Liu W, Liu F, Nasr K, Misra P, et al. (2010) Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 5: 42-47.
14. Polom K, Murawa D, Rho YS, Nowaczyk P, Hunerbein M, et al. (2011) Current trends and emerging future of indocyanine green usage in surgery and oncology: A Literature Review. Cancer 117: 4812-4822.
15. Predina JD, Judy B, Aliperti LA, Fridlender ZG, Blouin A, et al. (2011) Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models. Cancer Gene Ther 18: 871-883.
16. Predina JD, Judy B, Kapoor V, Blouin A, Aliperti LA, et al. (2012) Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment. Am J Transl Res 4: 206-218.
17. 1. J Immunol 171: 5051-5063.
18. Mohs AM, Mancini MC, Singhal S, Provenzale JM, Leyland-Jones B, et al. (2010) Hand-held Spectroscopic Device for In Vivo and Intraoperative Tumor Detection: Contrast Enhancement, Detection Sensitivity, and Tissue Penetration. Anal Chem 82:9058-9065.
19. Okusanya OT, Madajewski B, Segal E, Judy BF, Venegas OG, et al. (2013) Small Portable Interchangeable Imager of Fluorescence for Fluorescence Guided Surgery and Research. Technol Cancer Res Treat.
20. Baldwin HS, Shen HM, Yan HC, DeLisser HM, Chung A, et al. (1994) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120: 2539-2553.
21. Judy BF, Aliperti LA, Predina JD, Levine D, Kapoor V, et al. (2012) Vascular endothelial-targeted therapy combined with cytotoxic chemotherapy induces inflammatory intratumoral infiltrates and inhibits tumor relapses after surgery. Neoplasia 14: 352-359.
22. Predina JD, Kapoor V, Judy BF, Cheng G, Fridlender ZG, et al. (2012) Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness. J Hematol Oncol 5: 34-45.
23. Predina JD, Judy B, Fridlender ZG, Aliperti LA, Madajewski B, et al. (2012) A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation. Cancer Biol Ther 13: 745-755.
24. Ou SH, Zell JA, Ziogas A, Anton-Culver H (2008) Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. Chest 133: 662-669. (Pubitemid 351367374)
25. Detterbeck FC, Boffa DJ, Tanoue LT (2009) The new lung cancer staging system. Chest 136: 260-271.
26. Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13: 195-208. (Pubitemid 36790510)
27. van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, et al. (2013) Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer 119: 3411-3418.
28. Greish K (2010) Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 624: 25-37.
29. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, et al. (2013) Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology. Cancer Res 73: 2412-2417.
30. Greish K (2007) Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 15: 457-464.
31. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70. (Pubitemid 30046295)
32. de Oliveira RR, Martins CS, Rocha YR, Braga AB, Mattos RM, et al. (2013) Experimental diabetes induces structural, inflammatory and vascular changes of achilles tendons. PLoS ONE 8: e74942.
33. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, et al. (2011) Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies. J Nucl Med.
34. Hutteman M, Mieog JS, van der Vorst JR, Dijkstra J, Kuppen PJ, et al. (2011) Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin alpha(v)beta(3) expression in a syngeneic rat model. Eur J Surg Oncol 37: 252-257.
35. Crane LM, Themelis G, Pleijhuis RG, Harlaar NJ, Sarantopoulos A, et al. (2011) Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol 13: 1043-1049.